GUJARAT THEMIS BIOSYN
Quarterly Results Analysis [Mar2025]
GUJARAT THEMIS BIOSYN Quarterly Results
Standalone | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 Audited |
Jun2024 UnAudited |
Mar2024 Audited |
Dec2023 Audited |
Sep2023 Audited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹38 Cr | ₹40 Cr | ₹35 Cr | ₹39 Cr | ₹42 Cr | ₹39 Cr | ₹40 Cr | ₹50 Cr |
Expenses | ₹22 Cr | ₹21 Cr | ₹19 Cr | ₹20 Cr | ₹21 Cr | ₹21 Cr | ₹23 Cr | ₹26 Cr |
Operating Income | ₹16 Cr | ₹19 Cr | ₹15 Cr | ₹19 Cr | ₹21 Cr | ₹18 Cr | ₹17 Cr | ₹24 Cr |
Other Income | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹16 Cr | ₹17 Cr | ₹14 Cr | ₹18 Cr | ₹21 Cr | ₹18 Cr | ₹17 Cr | ₹24 Cr |
Profit After Tax | ₹12 Cr | ₹13 Cr | ₹11 Cr | ₹13 Cr | ₹16 Cr | ₹13 Cr | ₹13 Cr | ₹18 Cr |
EPS | ₹1.10 | ₹1.19 | ₹0.97 | ₹1.21 | ₹1.46 | ₹1.19 | ₹1.15 | ₹1.63 |
Industry Peers & Returns | 1W | 1M | 1Y |
GUJARAT THEMIS BIOSYN | 0.8% | 6.3% | 6.1% |
SUN PHARMACEUTICAL INDUSTRIES | -0% | -0.4% | 10.2% |
DIVIS LABORATORIES | 1.4% | 4.1% | 50.3% |
CIPLA | 0.5% | 1.6% | 1.4% |
TORRENT PHARMACEUTICALS | -1.2% | 7.1% | 18.3% |
DR REDDYS LABORATORIES | 1.7% | 1.2% | 1.5% |
MANKIND PHARMA | 5% | 3.3% | 11% |
ZYDUS LIFESCIENCES | 1.2% | 4.8% | -7% |
LUPIN | 2% | -0.9% | 19.8% |
GUJARAT THEMIS BIOSYN Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -4.51 % |
Y-o-Y | -10.18 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹38 Cr | -4.51 | |
Dec2024 | ₹40 Cr | 13.84 | |
Sep2024 | ₹35 Cr | -10.59 | |
Jun2024 | ₹39 Cr | -7.58 | |
Mar2024 | ₹42 Cr | 8.34 | |
Dec2023 | ₹39 Cr | -1.94 | |
Sep2023 | ₹40 Cr | -20.25 | |
Jun2023 | ₹50 Cr | - |
GUJARAT THEMIS BIOSYN Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -14.99 % |
Y-o-Y | -23.37 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹16 Cr | -14.99 | |
Dec2024 | ₹19 Cr | 22.58 | |
Sep2024 | ₹15 Cr | -17.03 | |
Jun2024 | ₹19 Cr | -11.37 | |
Mar2024 | ₹21 Cr | 18.47 | |
Dec2023 | ₹18 Cr | 5.64 | |
Sep2023 | ₹17 Cr | -28.85 | |
Jun2023 | ₹24 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -10.98 % |
Y-o-Y | -14.69 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 42.5% | -10.98 | |
Dec2024 | 47.74% | 7.69 | |
Sep2024 | 44.33% | -7.22 | |
Jun2024 | 47.78% | -4.09 | |
Mar2024 | 49.82% | 9.35 | |
Dec2023 | 45.56% | 7.73 | |
Sep2023 | 42.29% | -10.78 | |
Jun2023 | 47.4% | - |
GUJARAT THEMIS BIOSYN Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -7.52 % |
Y-o-Y | -24.48 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹12 Cr | -7.52 | |
Dec2024 | ₹13 Cr | 22.76 | |
Sep2024 | ₹11 Cr | -20.17 | |
Jun2024 | ₹13 Cr | -16.68 | |
Mar2024 | ₹16 Cr | 22.09 | |
Dec2023 | ₹13 Cr | 3.74 | |
Sep2023 | ₹13 Cr | -29.22 | |
Jun2023 | ₹18 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -3.14 % |
Y-o-Y | -15.92 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 31.79 % | -3.14 | |
Dec2024 | 32.82 % | 7.82 | |
Sep2024 | 30.44 % | -10.71 | |
Jun2024 | 34.09 % | -9.84 | |
Mar2024 | 37.81 % | 12.66 | |
Dec2023 | 33.56 % | 5.80 | |
Sep2023 | 31.72 % | -11.25 | |
Jun2023 | 35.74 % | - |
GUJARAT THEMIS BIOSYN Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -7.56 % |
Y-o-Y | -24.66 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹1.1 | -7.56 | |
Dec2024 | ₹1.19 | 22.68 | |
Sep2024 | ₹0.97 | -19.83 | |
Jun2024 | ₹1.21 | -17.12 | |
Mar2024 | ₹1.46 | 22.69 | |
Dec2023 | ₹1.19 | 3.48 | |
Sep2023 | ₹1.15 | -29.45 | |
Jun2023 | ₹1.63 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD